Sundar PichaiSundar Pichai earned $164M in 2023

R. Milton Johnson served as the CEO of HCA Healthcare from January 1, 2014, to December 31, 2018. Before stepping into the CEO role, he was the President and CFO since February 2011, and he has a long history with...

Quick Links
H

R. Milton Johnson

Ex-CEO of HCA Healthcare

Education

N/A

Field of Expertise

Finance & Banking - Finance

Sector of Economy

Healthcare

Born

June 30, 1954 - 70 years ago

CEO of HCA Healthcare for

4 years 11 months (Jan 2014 - Dec 2018)

Previous Experience

Executive Vice President and Chief Financial Officer of HCA

Holdings

See how much did R. Milton Johnson make over time.

During his time as CEO, R. Milton Johnson held considerable stock in HCA Healthcare, with about 881,823 shares at one point. This ownership reflects a significant personal stake in the company's success. His share value fluctuated over the years, aligning...

Total Stock Sold

$23.15M

HCA

$23.15M

281,284 HCA shares

What if they kept their stock?

If R. Milton Johnson didn't sell their stock, today they would have:
Extra HCA281,284 shares worth $30.40M.
This is 31.28% and $7.24M more than what they got when they sold the stock.

Charitable Transactions

HCA

435,899 shares

HCA

Recent Charitable Transactions

HCA

7,480 shares

HCA

Jan 30, 2019

Charity

HCA

21,795 shares

HCA

Jan 31, 2018

Charity

HCA

25,000 shares

HCA

Feb 22, 2017

Charity

HCA

59,000 shares

HCA

Jan 29, 2016

Charity

HCA

71,607 shares

HCA

Nov 8, 2012

Charity

HCA

251,017 shares

HCA

Nov 5, 2012

Charity

Insider Trading

See recent insider trades of R. Milton Johnson.

HCA

73,374 shares

HCA

Feb 21, 2019

Received

HCA

$749.95K

HCA at $139.06/share

Jan 30, 2019

Received

HCA

7,480 shares

HCA

Jan 30, 2019

Charity

HCA

124,800 shares

HCA

Feb 22, 2018

Received

HCA

21,795 shares

HCA

Jan 31, 2018

Charity

HCA

25,000 shares

HCA

Feb 22, 2017

Charity

HCA

59,000 shares

HCA

Jan 29, 2016

Charity

HCA

$11.80M

HCA at $83.89/share

Jun 11, 2015

Sale

HCA

$11.24M

HCA at $79.89/share

May 18, 2015

Sale

HCA

5,155 shares

HCA

Feb 25, 2014

Received

Compensation History

See how much did R. Milton Johnson make over time.

R. Milton Johnson's compensation as CEO of HCA Healthcare was quite notable, especially in the context of performance-driven incentives. In 2018, his total earnings surpassed $21 million, which included a base salary of around $1.5 million, a bonus of over $4.3 million, and a substantial vested stock value that accounted for nearly $13.8 million. His pay was closely linked to the company's performance on financial measures and patient care quality, reflecting a compensation philosophy aimed at incentivizing executives to meet specific goals. Throughout his leadership, Johnson's compensation fluctuated based on the company's financial success and quality metrics, reinforcing the idea that pay should reflect contributions to the company’s results. Interestingly, the median salary of HCA's employees was about $56,000, showing the large disparity typical of C-suite compensation in major corporations.

Year

2018

Total Compensation

$20.93M

Salary

$1.49M

Board Justification

The compensation philosophy of HCA Healthcare is to align executive compensation with company performance, peer benchmarking, and retention strategies, ensuring that a significant portion of compensation is performance-based.

Bonus

$4.32M

Board Justification

The amount Mr. Johnson would be entitled to receive for the 2018 fiscal year pursuant to the 2018 PEP and his employment agreement, which amount is also included in the 'Non-Equity Incentive Plan Compensation' column of the 2018 Summary Compensation Table.

Other

$1.35M

Board Justification

Includes contributions to retirement plans, life insurance premiums, and other compensation.

Restricted Stock

$13.76M(136.82K RSU)

Board Justification

The value of the stock that vested in 2018, including performance share units (PSUs) and restricted stock units (RSUs).

Performance Metrics

The performance metrics for the CEO's compensation in 2018 included financial performance based on EBITDA and quality metrics related to patient care.